A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
about
The renaissance of complement therapeutics.Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways.Expanding horizons in complement drug discovery: challenges and emerging strategies.Interpretation of Serological Complement Biomarkers in Disease
P2860
A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A double-blind randomised cont ...... a randomised controlled trial.
@ast
A double-blind randomised cont ...... a randomised controlled trial.
@en
type
label
A double-blind randomised cont ...... a randomised controlled trial.
@ast
A double-blind randomised cont ...... a randomised controlled trial.
@en
prefLabel
A double-blind randomised cont ...... a randomised controlled trial.
@ast
A double-blind randomised cont ...... a randomised controlled trial.
@en
P2093
P2860
P50
P1433
P1476
A double-blind randomised cont ...... a randomised controlled trial.
@en
P2093
Anass Qasem
Irene Rebollo-Mesa
Jonathon Olsburgh
Laura L Nichols
Martin Drage
Richard A Smith
Roseanna Greenlaw
Theodoros Kassimatis
P2860
P2888
P356
10.1186/S13063-017-1972-X
P577
2017-06-06T00:00:00Z
P6179
1085900779